☆ 4.5 Article

Pegylated interferon-α2b and ribavirin combination therapy induces Hashitoxicosis followed by type 1 diabetes mellitus

DIABETES RESEARCH AND CLINICAL PRACTICE (2012)

Get Full Text
Add to Collection

Journal

DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 95, Issue 3, Pages E52-E54

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.diabres.2011.11.016

Keywords

Interferon alpha; Ribavirin; Hashitoxicosis; Type 1 diabetes mellitus

Categories

Endocrinology & Metabolism

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

The combination of pegylated interferon-alpha 2b (PEG-IFN alpha) and ribavirin (RBV) is a standard treatment for chronic hepatitis C. The case of a patient with chronic hepatitis C who developed Hashitoxicosis followed by type 1 diabetes mellitus (T1DM) with PEG-IFN alpha plus RBV combination therapy, but not IFN alpha alone, is presented. (C) 2011 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.